Retrospective analysis of ribociclib and letrozole as first-line therapy in patients with hormone receptor (HR) positive metastatic breast cancer (MBC) within a managed access program (MAP) in Turkey

Başaran G. , Demirci U., Yıldız F., Çiçin İ., Aktaş B. Y. , Öztürk B., ...More

American Society of Clinical Oncology (ASCO) Annual Meeting, Illinois, United States Of America, 29 - 31 May 2020, pp.13055

  • Publication Type: Conference Paper / Summary Text
  • Doi Number: 10.1200/jco.2020.38
  • City: Illinois
  • Country: United States Of America
  • Page Numbers: pp.13055